Protocol M14-234: A Multicenter, Randomized, Double-Blind, Placebo -Controlled Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis

Project: Research project

Project Details

StatusFinished
Effective start/end date7/23/19 → 7/23/22

Funding

  • AbbVie Inc. (Prot# M14-234)